ArticleScientific reports2019

Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.

Grzegorz Kreiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.